NewGenIvf Group Limited (NIVF)

NASDAQ: NIVF · IEX Real-Time Price · USD

0.920

-0.040 (-4.16%)

At close: Jul 19, 2024, 4:00 PM

0.950

+0.030 (3.24%)

Pre-market: Jul 22, 2024, 7:00 AM EDT

NewGenIvf Group Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	0	0	0	4.12
Cost of Revenue	0	0	0	3.09
Gross Profit	0	0	0	1.02
Selling, General & Admin	2.52	2.52	0.5	0.83
Operating Expenses	2.52	2.52	0.5	0.83
Operating Income	-2.52	-2.52	-0.5	0.2
Interest Expense / Income	0	0	0	0.09
Other Expense / Income	-1.83	-1.83	-1.01	-0.18
Pretax Income	-0.69	-0.69	0.5	0.29
Income Tax	0	0	0	0.29
Net Income	-0.69	-0.69	0.5	-0
Shares Outstanding (Basic)	5	5	8	1
Shares Outstanding (Diluted)	5	5	8	1
Shares Change	-29.91%	-29.91%	1283.51%	-
EPS (Basic)	-1.23	-1.23	-1.28	-
EPS (Diluted)	-1.23	-1.23	-1.28	-
Free Cash Flow	-0.86	-0.86	-0.53	1.42
Free Cash Flow Per Share	-0.16	-0.16	-0.07	2.53
Gross Margin	-	-	-	24.88%
Operating Margin	-	-	-	4.83%
Profit Margin	-	-	-	-0.01%
Free Cash Flow Margin	-	-	-	34.39%
Effective Tax Rate	-	-	-	100.18%
EBITDA	-0.69	-0.69	0.5	0.73
EBITDA Margin	-	-	-	17.61%
Depreciation & Amortization	0	0	0	0.34
EBIT	-0.69	-0.69	0.5	0.38
EBIT Margin	-	-	-	9.29%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).